[ISEA2009] Artists Statement: Will Pappenheimer & John Craig Freeman – Virta-Flaneurazine: Clinical Study, 2008–2009

Artists Statement

Virtual/physical installation, performance and computer programme

Virta-Flaneurazine (VF) is a potent programmable mood-changing drug for Second Life (SL). It is identified as part of the Wanderment family of psychotropic drugs because it automatically causes the user to aimlessly roam the distant lands of online 3D worlds. VF was originally developed to treat Wanderlust Deficit Disorder (WDD) an increasingly common disorder characterised by long hours of rote repetitive Internet use and the inability of individuals to depart from their daily routines in both their physical and virtual lives.  virtaflaneurazine.wordpress.com

  • Will Pappenheimer is an artist and professor at Pace University, New York, USA.
  • John Craig Freeman is currently an Associate Professor of New Media at Emerson College Boston, USA

Full text (PDF) p. 42